Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
potassium/inflammation
Länken sparas på Urklipp
Sida 1 från 55 resultat
(-)-Hydroxycitric acid for controlling inflammation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to pharmaceutical compositions containing (-)-hydroxycitric acid useful for reducing inflammation and regulating inflammatory responses and processes.
2. Description Of Prior Art
Chronic inflammation recently has received
Crystalline potassium salt of lipoxin A4 analogs
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The invention relates to the crystalline potassium salts of lipoxin A.sub.4 analogs, their use in treating a disease-state characterized by inflammation, and pharmaceutical compositions containing the crystalline potassium salts of the analogs and processes for their preparation.
Lipoxins, together
Crystalline potassium salt of lipoxin A.sub.4 analogs
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The invention relates to the crystalline potassium salts of lipoxin A.sub.4 analogs, their use in treating a disease-state characterized by inflammation, and pharmaceutical compositions containing the crystalline potassium salts of the analogs and processes for their preparation.
Lipoxins, together
Ophthalmic and aural compositions containing diclofenac potassium
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The present invention describes an ophthalmic composition comprising diclofenac potassium, the use of said composition as a medicament for treating inflammatory conditions of the eye, for treating glaucoma or for treating ear inflammatory and/or painful conditions (otitis); as well as the use of
Ophthalmic and aural compositions containing diclofenac potassium
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application claims priority to European Patent Application No. 95/03844, filed on Sep. 28, 1995.
The present invention describes an ophthalmic composition comprising diclofenac potassium, the use of said composition as a medicament for treating inflammatory conditions of the eye, for treating
Potassium-dependent sodium-calcium exchanger
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
This invention relates to a potassium-dependent sodium-calcium exchanger useful in screening an agent for treating a cell injury due to postischemic reperfusion and/or an inflammatory disease.
BACKGROUND ART
During ischemia, an organ proceeds via a reversible to the irreversible
Potassium channel blockers and uses thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and
Amine derivatives as potassium channel blockers
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and
Amine derivatives as potassium channel blockers
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and
Benzofuran potassium channel blockers and uses thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and
Aryl potassium channel blockers and uses thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and
Chromenone potassium channel blockers and uses thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and
Thieno[3,2-c]pyridine potassium channel inhibitors
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to thienopyridine compounds which are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment or prevention of cancer, arrhythmias, autoimmune diseases and
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
This invention relates to the fields of pharmaceutical and organic chemistry. Embodiments of the present invention relate to, and provide spiro azepane-oxazolidinones(1-oxa-3,8-diazaspiro-[4.6]undecan-2-ones) as voltage gated Kv1.3 potassium channel blockers, and intermediates,
Treatment of optic and otic inflammation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to non-steroidal anti-inflammatory compositions for treating optic and/or otic inflammations and irritations. More particularly, there is provided a composition of inorganic salts which can be used over a long period of time to reduce inflammation
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
